Yan-Ting Sun
Research Subjects
Yan-Ting Sun has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Yun-Tai Yao
Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
6 shared publications the Evidence in Cardiovascular Anesthesia (EICA) Group
Department of Anesthesiology, Baoji High-Tech Hospital, Shaanxi, China
4 shared publications- Huaqiu Chen
Department of Laboratory, Xichang People’s Hospital, Liangshan, Sichuan, China
1 shared publication - Jian-Qun Liang
Department of Digestive Endoscopy Center, Baoji High-Tech Hospital, Shaanxi, China
1 shared publication - Li-Hong Wang
Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
1 shared publication - Qiqing Lan
Department of Anesthesiology, Xichang People’s Hospital, Xichang, China
1 shared publication
Latest Publications
- Open Access
- 25 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (30) , e43567
A bibliometric analysis of the published studies in ciprofol research
Objective: Ciprofol (HSK-3486), a novel intravenous anesthetic with structural similarities to propofol, has shown promising pharmacokinetic (PK) and pharmacodynamic (PD) profiles; however, clinical data regarding its efficacy and safety remain limited. Because research on ciprofol is still in its infancy, this study uses bibliometric methods to examine the published literature and to highlight research trends, key topics, and future directions for its clinical applications. Methods: We searched the Web of Science Core Collection (WoSCC) for English-language articles and reviews on ciprofol published from 2017 – the year it was first reported – through August 28, 2024. Two authors independently screened titles and abstracts for eligibility, discrepancies were resolved in consultation with a senior reviewer. The data, including publication details and citation metrics, were extracted and organized for analysis. We visualized the results with CiteSpace, GraphPad Prism, and Microsoft Excel. Results: A total of 62 studies were included. Annual publications rose by 50% from 2021 to 2022 and by 83% from 2022 to 2023. China dominated the field, contributing 59 articles (95.16% of the total). Sichuan University and Liu X. were the most prolific institution and author, respectively. BMC Anesthesiology, Drug Design, Development and Therapy, Frontiers in Pharmacology, and Journal of Clinical Anesthesia were the 4 leading journals publishing ciprofol research. Frontiers in Pharmacology received the most citations (n = 71) and achieved an H-index of 4. Anesthesiology carried the highest 2022 impact factor (9.1), whereas Anesthesia and Analgesia accrued 48 citations. Safety, pharmacokinetics, and anesthesia were the most frequently studied aspects, whereas “critically ill patients,” “injection,” and “pain” emerged as recent research hotspots. Temporal analysis showed that key terms shifted from “pharmacokinetics” in 2021 to “general anesthesia” by 2022, while themes such as “critically ill patients” remained consistently relevant. Conclusion: This bibliometric analysis provides a comprehensive overview of ciprofol research, identifies key contributors, and reveals critical insights and gaps in the literature. Our findings underscore ciprofol’s safety, efficacy, and optimal clinical use while highlighting current hotspots and challenges that should guide future research.
- 25 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (30) , e43567
Open AccessA bibliometric analysis of the published studies in ciprofol research
Objective: Ciprofol (HSK-3486), a novel intravenous anesthetic with structural similarities to propofol, has shown promising pharmacokinetic (PK) and pharmacodynamic (PD) profiles; however, clinical data regarding its efficacy and safety remain limited. Because research on ciprofol is still in its infancy, this study uses bibliometric methods to examine the published literature and to highlight research trends, key topics, and future directions for its clinical applications. Methods: We searched the Web of Science Core Collection (WoSCC) for English-language articles and reviews on ciprofol published from 2017 – the year it was first reported – through August 28, 2024. Two authors independently screened titles and abstracts for eligibility, discrepancies were resolved in consultation with a senior reviewer. The data, including publication details and citation metrics, were extracted and organized for analysis. We visualized the results with CiteSpace, GraphPad Prism, and Microsoft Excel. Results: A total of 62 studies were included. Annual publications rose by 50% from 2021 to 2022 and by 83% from 2022 to 2023. China dominated the field, contributing 59 articles (95.16% of the total). Sichuan University and Liu X. were the most prolific institution and author, respectively. BMC Anesthesiology, Drug Design, Development and Therapy, Frontiers in Pharmacology, and Journal of Clinical Anesthesia were the 4 leading journals publishing ciprofol research. Frontiers in Pharmacology received the most citations (n = 71) and achieved an H-index of 4. Anesthesiology carried the highest 2022 impact factor (9.1), whereas Anesthesia and Analgesia accrued 48 citations. Safety, pharmacokinetics, and anesthesia were the most frequently studied aspects, whereas “critically ill patients,” “injection,” and “pain” emerged as recent research hotspots. Temporal analysis showed that key terms shifted from “pharmacokinetics” in 2021 to “general anesthesia” by 2022, while themes such as “critically ill patients” remained consistently relevant. Conclusion: This bibliometric analysis provides a comprehensive overview of ciprofol research, identifies key contributors, and reveals critical insights and gaps in the literature. Our findings underscore ciprofol’s safety, efficacy, and optimal clinical use while highlighting current hotspots and challenges that should guide future research.
- Open Access
- 2 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (18) , e42333
Vasoactive-inotropic agents in pediatric patients undergoing cardiac surgery: A single-center retrospective study
This study aimed to retrospectively summarize the use of vasoactive-inotropic agents in pediatric patients undergoing cardiac surgery at Fuwai Hospital. A total of 401 patients who met the screening criteria were enrolled in this study between April and June 2021 at Fuwai Hospital. We retrospectively summarized the current practices for vasoactive-inotropic agent use across different ages, Risk Adjustment in Cardiac Surgery 1 (RACHS-1) categories, and among various anesthesiologists. Intraoperatively, milrinone was the most commonly used inotrope (327 patients, 81.6%), followed by dopamine (274, 68.3%), dobutamine (263, 65.4%), epinephrine (67, 16.7%), and isoprenaline (11, 2.7%). Vasopressin was mainly administered during the pediatric intensive care unit period, with the highest use rate on postoperative day (POD)-1 (16/401, 3.9%). Furthermore, a combination of dopamine, dobutamine, and milrinone was administered by 52.1% of anesthesiologists intraoperatively and by 30.2% of pediatric intensivists on POD 1. Milrinone, dopamine, and dobutamine were selected by most anesthesiologists (13/14, 92.9%), and their usage rates among different anesthesiologists ranged from 66.67% to 92.68%, 52.94% to 89.66%, and 46.18% to 86.21%, respectively. Moreover, their use in category 4 surgeries was significantly higher than in category 1 to 3 surgeries. Milrinone, dopamine, and dobutamine were the most commonly used vasoactive-inotropic agents, while the other agents represented the diversity of medications used during both the intra- and postoperative periods in pediatric cardiac surgery at Fuwai Hospital.
- 2 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (18) , e42333
Open AccessVasoactive-inotropic agents in pediatric patients undergoing cardiac surgery: A single-center retrospective study
This study aimed to retrospectively summarize the use of vasoactive-inotropic agents in pediatric patients undergoing cardiac surgery at Fuwai Hospital. A total of 401 patients who met the screening criteria were enrolled in this study between April and June 2021 at Fuwai Hospital. We retrospectively summarized the current practices for vasoactive-inotropic agent use across different ages, Risk Adjustment in Cardiac Surgery 1 (RACHS-1) categories, and among various anesthesiologists. Intraoperatively, milrinone was the most commonly used inotrope (327 patients, 81.6%), followed by dopamine (274, 68.3%), dobutamine (263, 65.4%), epinephrine (67, 16.7%), and isoprenaline (11, 2.7%). Vasopressin was mainly administered during the pediatric intensive care unit period, with the highest use rate on postoperative day (POD)-1 (16/401, 3.9%). Furthermore, a combination of dopamine, dobutamine, and milrinone was administered by 52.1% of anesthesiologists intraoperatively and by 30.2% of pediatric intensivists on POD 1. Milrinone, dopamine, and dobutamine were selected by most anesthesiologists (13/14, 92.9%), and their usage rates among different anesthesiologists ranged from 66.67% to 92.68%, 52.94% to 89.66%, and 46.18% to 86.21%, respectively. Moreover, their use in category 4 surgeries was significantly higher than in category 1 to 3 surgeries. Milrinone, dopamine, and dobutamine were the most commonly used vasoactive-inotropic agents, while the other agents represented the diversity of medications used during both the intra- and postoperative periods in pediatric cardiac surgery at Fuwai Hospital.
- Open Access
- 22 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (12) , e37472
Iatrogenic aortic dissection in patients undergoing coronary artery bypass grafting surgery: A systemic review of published literatures
Background: Iatrogenic aortic dissection (IAD) is a rare but highly lethal complication that may occur following coronary artery bypass grafting (CABG) surgery. Aortic dissection (AD) is often asymptomatic, making early detection difficult. We aimed to optimize preoperative evaluation strategies of CABG surgery for minimizing the incidence of IAD and assess early recognition and management of IAD for improving outcomes. Methods: Electronic databases were searched to identify all case reports of patients undergoing CABG surgery who developed IAD. Clinical characteristics, operative information, perioperative management, and patient outcomes were compiled and analyzed. Results: Nineteen case reports involving 27 patients aged 50 to 81 were included. Patients were from Europe (n = 23) and Asia (n = 4), mostly men (n = 25). The aorta was described as normal, abnormal, and unmentioned (n = 8, 5, and 14, respectively). Sixteen patients had a bypass with more than 3 grafts. Most patients (n = 25) experienced type A dissection. There were intraoperative (n = 12) and postoperative (n = 15) cases. Surgery (n = 19) was the most common treatment, with 9 patients selecting deep hypothermic circulatory arrest. Eighteen patients were restored to health, while 9 patients died (3 died before treatment). Conclusions: Our study focused on patients with IAD and developed a recommended management protocol for patients undergoing CABG surgery.
- 22 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (12) , e37472
Open AccessIatrogenic aortic dissection in patients undergoing coronary artery bypass grafting surgery: A systemic review of published literatures
Background: Iatrogenic aortic dissection (IAD) is a rare but highly lethal complication that may occur following coronary artery bypass grafting (CABG) surgery. Aortic dissection (AD) is often asymptomatic, making early detection difficult. We aimed to optimize preoperative evaluation strategies of CABG surgery for minimizing the incidence of IAD and assess early recognition and management of IAD for improving outcomes. Methods: Electronic databases were searched to identify all case reports of patients undergoing CABG surgery who developed IAD. Clinical characteristics, operative information, perioperative management, and patient outcomes were compiled and analyzed. Results: Nineteen case reports involving 27 patients aged 50 to 81 were included. Patients were from Europe (n = 23) and Asia (n = 4), mostly men (n = 25). The aorta was described as normal, abnormal, and unmentioned (n = 8, 5, and 14, respectively). Sixteen patients had a bypass with more than 3 grafts. Most patients (n = 25) experienced type A dissection. There were intraoperative (n = 12) and postoperative (n = 15) cases. Surgery (n = 19) was the most common treatment, with 9 patients selecting deep hypothermic circulatory arrest. Eighteen patients were restored to health, while 9 patients died (3 died before treatment). Conclusions: Our study focused on patients with IAD and developed a recommended management protocol for patients undergoing CABG surgery.
- Open Access
- 10 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (45) , e35570
Cardiovascular anesthesia training: A single center survey among fellow doctors
Despite the proliferation of research on anesthesiology training at all stages of medical education, there is relatively little published literature surveying the perspectives and concerns of anesthesiologists regarding cardiovascular anesthesia training. Therefore, we conducted a survey to investigate the attitudes, barriers, expectations, stress experiences, satisfaction, and future aspirations of anesthesiologists trained at a tertiary cardiovascular specialty hospital in China. A questionnaire survey was conducted among 260 anesthesiologists who received cardiovascular anesthesia training at departments of anesthesiology in a tertiary cardiovascular specialty hospital in China. After the study protocol was approved, electronic questionnaires were distributed to the target group through the online survey software “Wen Juan Xing.” Respondents were asked to complete an anonymous questionnaire on their smartphones through WeChat, with the restriction of one response per device enabled. Of the 260 trainees, 240 (98%) completed the questionnaire. The majority of the trainees were 31 years of age or above. A large majority had approximately 10 years of clinical anesthesia practice, and nearly one-third had never undertaken cardiovascular specialty anesthesia practice before. The most common reasons for attending the refresher training were the need to learn basic specialty theory and improve clinical skills. The barriers were mainly time constraints or staff shortages in the department. Sixty-one (93.8%) trainees described the experience as “stressful or highly stressful” and identified poor teacher interaction as the highest-ranking stressor. Anesthesiologists were most dissatisfied with job rewards, with a satisfaction rate of only 15%. Anesthesiologists are highly stressed during the refresher training. Poor teacher interaction and low job rewards were identified as the highest-ranking stressors during cardiovascular anesthesia training. Training providers need to pay more attention to these stressors to enhance the quality of cardiovascular anesthesia training.
- 10 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (45) , e35570
Open AccessCardiovascular anesthesia training: A single center survey among fellow doctors
Despite the proliferation of research on anesthesiology training at all stages of medical education, there is relatively little published literature surveying the perspectives and concerns of anesthesiologists regarding cardiovascular anesthesia training. Therefore, we conducted a survey to investigate the attitudes, barriers, expectations, stress experiences, satisfaction, and future aspirations of anesthesiologists trained at a tertiary cardiovascular specialty hospital in China. A questionnaire survey was conducted among 260 anesthesiologists who received cardiovascular anesthesia training at departments of anesthesiology in a tertiary cardiovascular specialty hospital in China. After the study protocol was approved, electronic questionnaires were distributed to the target group through the online survey software “Wen Juan Xing.” Respondents were asked to complete an anonymous questionnaire on their smartphones through WeChat, with the restriction of one response per device enabled. Of the 260 trainees, 240 (98%) completed the questionnaire. The majority of the trainees were 31 years of age or above. A large majority had approximately 10 years of clinical anesthesia practice, and nearly one-third had never undertaken cardiovascular specialty anesthesia practice before. The most common reasons for attending the refresher training were the need to learn basic specialty theory and improve clinical skills. The barriers were mainly time constraints or staff shortages in the department. Sixty-one (93.8%) trainees described the experience as “stressful or highly stressful” and identified poor teacher interaction as the highest-ranking stressor. Anesthesiologists were most dissatisfied with job rewards, with a satisfaction rate of only 15%. Anesthesiologists are highly stressed during the refresher training. Poor teacher interaction and low job rewards were identified as the highest-ranking stressors during cardiovascular anesthesia training. Training providers need to pay more attention to these stressors to enhance the quality of cardiovascular anesthesia training.
- Open Access
- 11 August 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (32) , e34508
Anesthesia management of patients undergoing thoracic endovascular aortic repair: A retrospective analysis of single center
Thoracic endovascular aortic repair (TEVAR) is a new alternative surgical treatment for aortic pathologies, which is more minimally invasive. The aim of current study was to summarize the single-center experience of general anesthesia for patients undergoing TEVAR. In adult patients undergoing surgery for congenital heart disease, the strategy of “fast-track” anesthesia with early extubation in theater is associated with a shorter intensive care unit (ICU) stay, and lower health-care-related costs. Fast-track anesthesia has not been assessed in patients under TEVAR. Adult patients who received general anesthesia for TEVAR in our center from January 2020 to December 2020 were included. Baseline characteristics, airway management, anesthetic techniques and major complications were collected. A total of 204 (171 male, mean age 58.1 ± 11.5 years) patients met inclusion criteria for this study. The distribution of pathologies included 29 descending thoracic aneurysms, 87 type B dissections, and 88 intramural hematoma/perforating aortic ulcer. Etomidate was the induction agent in 190 (93.1%) patients, compared with propofol in 16 (7.8%). Cisatracurium was the muscle relaxant in 201 (98.5%), compared with rocuronium in 3 (1.5%). Midazolam (benzodiazepines) was given to 124 (60.8%) patients during anesthesia induction. General anesthesia was maintained with sevoflurane in 85.3% (174) patients, dexmedetomidine in 201 (98.5%) and propofol in 204 (100%). Postoperative length of stay (LOS) in the hospital was 6.0 (5.0–7.8) days. LOS in the ICU was 23.0 (20.0–27.8) hours. Overall neurologic event rate was 2.0% (n = 4) (spinal cord ischemia 1.5% [n = 3]; stroke 0.5% [n = 1]). After matching, patients who received “fast-track” anesthesia had a shorter LOS in ICUs (21.0 [18.0–24.0] vs 24.0 [20.0–44.0] hours; P = .005), and a shorter postoperative LOS in hospital (5.0 [4.0–7.0] vs 6.0 [5.0–8.0] days; P = .001). There were no in-hospital deaths. Fast-track anesthesia is feasible and safe in patients underwent TEVAR. This management strategy is associated with shorter LOS of ICU and total postoperative hospital stays. An early extubation strategy should be implemented for hemodynamically stable patients.
- 11 August 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (32) , e34508
Open AccessAnesthesia management of patients undergoing thoracic endovascular aortic repair: A retrospective analysis of single center
Thoracic endovascular aortic repair (TEVAR) is a new alternative surgical treatment for aortic pathologies, which is more minimally invasive. The aim of current study was to summarize the single-center experience of general anesthesia for patients undergoing TEVAR. In adult patients undergoing surgery for congenital heart disease, the strategy of “fast-track” anesthesia with early extubation in theater is associated with a shorter intensive care unit (ICU) stay, and lower health-care-related costs. Fast-track anesthesia has not been assessed in patients under TEVAR. Adult patients who received general anesthesia for TEVAR in our center from January 2020 to December 2020 were included. Baseline characteristics, airway management, anesthetic techniques and major complications were collected. A total of 204 (171 male, mean age 58.1 ± 11.5 years) patients met inclusion criteria for this study. The distribution of pathologies included 29 descending thoracic aneurysms, 87 type B dissections, and 88 intramural hematoma/perforating aortic ulcer. Etomidate was the induction agent in 190 (93.1%) patients, compared with propofol in 16 (7.8%). Cisatracurium was the muscle relaxant in 201 (98.5%), compared with rocuronium in 3 (1.5%). Midazolam (benzodiazepines) was given to 124 (60.8%) patients during anesthesia induction. General anesthesia was maintained with sevoflurane in 85.3% (174) patients, dexmedetomidine in 201 (98.5%) and propofol in 204 (100%). Postoperative length of stay (LOS) in the hospital was 6.0 (5.0–7.8) days. LOS in the ICU was 23.0 (20.0–27.8) hours. Overall neurologic event rate was 2.0% (n = 4) (spinal cord ischemia 1.5% [n = 3]; stroke 0.5% [n = 1]). After matching, patients who received “fast-track” anesthesia had a shorter LOS in ICUs (21.0 [18.0–24.0] vs 24.0 [20.0–44.0] hours; P = .005), and a shorter postoperative LOS in hospital (5.0 [4.0–7.0] vs 6.0 [5.0–8.0] days; P = .001). There were no in-hospital deaths. Fast-track anesthesia is feasible and safe in patients underwent TEVAR. This management strategy is associated with shorter LOS of ICU and total postoperative hospital stays. An early extubation strategy should be implemented for hemodynamically stable patients.
- 7 September 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (11) , 3654-3661
Vasoactive‐inotropic score/inotropic score and short‐term outcomes in pediatrics undergoing cardiac surgery: A retrospective analysis from single center
This study aimed to investigate the association between vasoactive-inotropic score/inotropic score (VIS/IS) and short-term outcomes in pediatric patients after cardiac surgery at a tertiary care center in an unselected pediatric population in China. This study carried out retrospective observation of 401 patients between April and June 2021 at a tertiary care center. VIS and IS were assessed intraoperatively (VIS-op, IS-op) and 2 h (VIS2h, IS2h), 24 h (VIS24h, IS24h), and 48 h (VIS48h, IS48h) postoperatively. The primary outcome was prolonged mechanical ventilation (PMV). Secondary outcomes included poor prognosis and length of stay in the pediatric intensive care unit and hospital. Mean age of the included pediatric patients was 26.5 months. Pediatric cardiac procedures were performed within an average operation duration of 167.6 ± 70.8 min. Overall, the PMV group (n = 93) experienced significantly longer ACC duration, cardiopulmonary bypass duration, operation duration, and a higher prevalence of fluid accumulation overload than the non-PMV group (n = 93). Multivariate logistic regression analysis revealed that longer operation duration (odds ratio [OR]: 1.015; 95% confidence interval [95% CI]: 1.003, 1.026; p = .012) and higher VIS48h (OR: 1.188; 95% CI: 1.077, 1.311; p = .001) were strongest predictors for PMV. VIS48h had better discrimination power for PMV than other time intervals, and the area under the curve was 0.780 (95% CI, 0.721, 0.839; p = .000). VIS48h independently predicted short-term outcomes after cardiac surgery in an unselected pediatric population in China and showed better prediction accuracy and discrimination capability than other time intervals.
- 7 September 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (11) , 3654-3661
Vasoactive‐inotropic score/inotropic score and short‐term outcomes in pediatrics undergoing cardiac surgery: A retrospective analysis from single center
This study aimed to investigate the association between vasoactive-inotropic score/inotropic score (VIS/IS) and short-term outcomes in pediatric patients after cardiac surgery at a tertiary care center in an unselected pediatric population in China. This study carried out retrospective observation of 401 patients between April and June 2021 at a tertiary care center. VIS and IS were assessed intraoperatively (VIS-op, IS-op) and 2 h (VIS2h, IS2h), 24 h (VIS24h, IS24h), and 48 h (VIS48h, IS48h) postoperatively. The primary outcome was prolonged mechanical ventilation (PMV). Secondary outcomes included poor prognosis and length of stay in the pediatric intensive care unit and hospital. Mean age of the included pediatric patients was 26.5 months. Pediatric cardiac procedures were performed within an average operation duration of 167.6 ± 70.8 min. Overall, the PMV group (n = 93) experienced significantly longer ACC duration, cardiopulmonary bypass duration, operation duration, and a higher prevalence of fluid accumulation overload than the non-PMV group (n = 93). Multivariate logistic regression analysis revealed that longer operation duration (odds ratio [OR]: 1.015; 95% confidence interval [95% CI]: 1.003, 1.026; p = .012) and higher VIS48h (OR: 1.188; 95% CI: 1.077, 1.311; p = .001) were strongest predictors for PMV. VIS48h had better discrimination power for PMV than other time intervals, and the area under the curve was 0.780 (95% CI, 0.721, 0.839; p = .000). VIS48h independently predicted short-term outcomes after cardiac surgery in an unselected pediatric population in China and showed better prediction accuracy and discrimination capability than other time intervals.